Skip to main content

Peer Review reports

From: Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study

Original Submission
30 Aug 2018 Submitted Original manuscript
15 Nov 2018 Author responded Author comments - Martin Boegemann
2 Oct 2018 Reviewed Reviewer Report - Chad Alan Reichard
8 Oct 2018 Reviewed Reviewer Report - Shawn Dason
Resubmission - Version 2
15 Nov 2018 Submitted Manuscript version 2
23 Dec 2018 Author responded Author comments - Martin Boegemann
14 Dec 2018 Reviewed Reviewer Report - Shawn Dason
Resubmission - Version 3
23 Dec 2018 Submitted Manuscript version 3
3 Jan 2019 Author responded Author comments - Martin Boegemann
Resubmission - Version 4
3 Jan 2019 Submitted Manuscript version 4
Publishing
7 Jan 2019 Editorially accepted
14 Jan 2019 Article published 10.1186/s12885-019-5280-6

You can find further information about peer review here.

Back to article page